Labs / Assays & in vitro testing
ProJect Pharmaceutics
Martinsried, Germany · project-pharmaceutics.com
GMP · GLP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
ProJect Pharmaceutics GmbH develops formulations and manufacturing processes for injectable therapeutic products. It works with recombinant proteins, antibodies, ADCs, peptides, small molecules, viral vectors, liposomes, and nanoparticle systems for preclinical through commercial development. The company is based in Martinsried, Munich, Germany, with business development representation in Boston, MA.
They take quote requests by email.
What they offer
Formulation development
Develops liquid and lyophilized injectable formulations for proteins, antibodies, peptides, ADCs, small molecules, and viral and nanoparticle systems.
Preformulation screening
Screens physicochemical properties and formulation variables to identify stable and developable lead formulations.
High concentration & subcutaneous formulation
Develops high-concentration formulations for subcutaneous delivery.
Lyophilization cycle development
Develops freeze-drying cycles for client formulations and manufacturer equipment.
Downstream process development
Develops purification and UF/DF steps around molecule stability and delivers drug substance in a usable formulation.
Analytical services & method development
Runs and develops analytical methods for biologics, ADCs, cytotoxics, and viral therapeutics, including method implementation and optimization.
Forced degradation & stress studies
Stresses lead formulations to identify degradation pathways and support formulation selection and method development.
In-use stability & clinical administration
Simulates site preparation, dilution, holding, infusion, and injection to assess in-use stability and administration compatibility.
Technology transfer to fill & finish
Develops formulations and fill-finish processes for transfer to a manufacturer’s filling line.
Non-GMP toxicology & stability batches
Makes aseptic non-GMP preclinical batches of liquid or lyophilized product for toxicology, PK/PD, and stability studies.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Peptide, Viral vector, Recombinant protein, Vaccine, LNP / formulation
- Assays and studies
- SE-HPLC, AF4, DLS, nanoDSC, CG-MALS, cIEF, icIEF, IEX-HPLC, electrophoresis, light scattering, calorimetry, chromatography, and 1 more
- Instruments and platforms
- HOF pilot freeze-dryers, Wyatt Technology
- Scale and capacity
- Up to 1,000 vials per batch, ~1,000 2R vials per biologics batch, 2R to 100H vial sizes, Up to OEB5 cytotoxic containment
- Therapeutic areas
- biologics, ADCs, cytotoxics, viral therapeutics, live viral vaccines
- Turnaround
- Within 5 days reporting of analytical results · Within 5 days reporting of results after testing · 2 to 4 weeks from scope alignment to project start · 5 to 6 weeks of cycle development
- What to send
- Final formulation · Container · Fill volume · Information on your manufacturer’s dryer · Target product profile · Intended manufacturer, if known
- Type
- CDMO
- Sites
- Martinsried, Germany · Munich, Germany · Boston, MA, United States
- Team
- 8+ years average scientist tenure
- Quality
- ICH Q8 · ICH Q5C · ICH Q1A(R2) · ICH Q1B · ICH S6(R1) · GLP-like documentation · Ph. Eur. · USP
- Address
- manufacturing 250+ short- and long-term stability runs completed 140 lyophili
- Founded
- 2010
Similar labs. Esco Aster, Aurigene Pharmaceutical Services, Sparx BIO, Biofidus GmbH
Found in a contract services directory. Listing built from project-pharmaceutics.com. Work here? Claim this listing.